Option Care Health (NASDAQ:OPCH) Rating Increased to Buy at Bank of America

Bank of America upgraded shares of Option Care Health (NASDAQ:OPCH) from a neutral rating to a buy rating in a research note released on Monday, Marketbeat Ratings reports. Bank of America currently has $33.00 price target on the stock, up from their previous price target of $26.00.

A number of other brokerages have also recently issued reports on OPCH. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and decreased their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Barrington Research decreased their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. UBS Group assumed coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Finally, JMP Securities reissued a “market outperform” rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and a consensus target price of $29.71.

Option Care Health Trading Up 15.5 %

OPCH stock opened at $27.72 on Monday. Option Care Health has a 52 week low of $21.39 and a 52 week high of $34.63. The company has a market cap of $4.72 billion, a price-to-earnings ratio of 23.29, a PEG ratio of 2.43 and a beta of 1.31. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business has a fifty day simple moving average of $23.20 and a 200-day simple moving average of $27.69.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company’s stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is currently owned by insiders.

Institutional Trading of Option Care Health

A number of hedge funds have recently made changes to their positions in the stock. Graypoint LLC acquired a new stake in Option Care Health in the fourth quarter valued at $1,161,000. Harbor Capital Advisors Inc. raised its stake in shares of Option Care Health by 2.7% in the 4th quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company’s stock valued at $4,945,000 after purchasing an additional 5,595 shares in the last quarter. Nordea Investment Management AB raised its stake in shares of Option Care Health by 6.0% in the 4th quarter. Nordea Investment Management AB now owns 94,641 shares of the company’s stock valued at $2,165,000 after purchasing an additional 5,365 shares in the last quarter. Central Pacific Bank Trust Division lifted its position in shares of Option Care Health by 6.9% during the fourth quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company’s stock worth $234,000 after purchasing an additional 650 shares during the last quarter. Finally, TD Private Client Wealth LLC grew its stake in Option Care Health by 21.4% in the third quarter. TD Private Client Wealth LLC now owns 5,723 shares of the company’s stock worth $179,000 after purchasing an additional 1,007 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.